Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Hospitalier de Vichy | OTHER |
Not provided
Not provided
Not provided
The investigators proposed to conduct a retrospective study to evaluate the impact of the implementation of apTeleCare software on the management of dialysis patients at home in terms of the number and duration of hospitalizations. For this purpose, the investigators will compare patients' data over a 2-year interval before the introduction of Telemonitoring (January 2012 and December 2013 inclusive - Group 1) with patients data who have benefited from this application (between August 2016 and July 2018).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients without Telemonitoring with ApTelecare Software | |||
| Patients with implementation of Telemonitoring with ApTelecare |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telemonitoring Software | Device | Recovery of retrospective data in dialysis patients follow or not follow by a telemonitoring application. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cumulative duration (on retrospective two years of follow-up) of the unscheduled hospitalizations between the two patient groups. | up to two years. | |
| Cumulative duration (on retrospective two years of follow-up) of the scheduled hospitalizations between the two patient groups. | up to two years. |
| Measure | Description | Time Frame |
|---|---|---|
| Total length of hospitalisation | For both groups. Every two months (follow-up visit) on a retrospective period of two years, the outcome 2 will be measured. The study duration will be of 5 months | |
| Number of events of cardiovascular complications | For both groups. Every two months (follow-up visit) on a retrospective period of two years. The study duration will be of 5 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with a chronic renal failure who are take care in the dialysis unit. These patients are their peritoneal dialysis at home and use or not the telemonitoring software "ApTelecare".
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Matthieu Merlot | Montpellier | 34184 | France |
Not provided
| ID | Term |
|---|---|
| D007676 | Kidney Failure, Chronic |
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Mortality rate | For both groups. At the end of this retrospective study (Study Period of 5 months). |
| Rate of peritoneal infections | For both groups. At the end of this retrospective study.(Study Period of 5 months). |
| Number of patient exit technique except death | For example transplant, hemodialysis | For both groups. At the end of this retrospective study. (Study Period of 5 months). |
| Charlson score : Comorbidity index | This scale measure the comorbidity symptoms of patients at the beginning of the care by the physician. The minimum score will be "0" and the maximum will be 39. Its validation is based on a prediction of health French insurance, as well as on several clinical areas such as oncology or nephrology. | baseline |
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |